BuzzSparks.org

Amyris Biotechnologies


Renewable Fuels

Amyris Biotechnologies creates renewable products, focusing on fuels and chemicals. The company plans to enter the market by 2011. The company is developing renewable fuels that reduce lifecycle (GHG) emissions 80%. The fuel source is special in...

Founded in 2003
Homepage:
Total money raised: $417M

94608 5885 Hollis Street, Suite 100

Emeryville
USA CA

Phone: (510) 450-0761

Updated on Mar 10, 2014
Amyris Biotechnologies at CrunchBase
Tags:   chemicals   cleantech   fuels   malaria   malaria-treatment   renewable   renewable-chemicals   renewable-fuels   treatment

John Melo President & CEO
Arthur D. Levinson Chairman, Director and Lead Independent Director
Christine Ring Senior Vice President & Chief Intellectual Property Counsel
Zanna McFerson Chief Business Officer
Steven R. Mills CFO
Joel Velasco Senior Vice President
Charles Kraft Vice President, Global Manufacturing & Process Development
Fernando Reinach board member
Geoffrey Duyk Board Member & Directors
Samir Kaul Investor
Nicholas Khadder General Counsel & Corporate Secretary
Karen Rohde Chief Human Resources Officer
Nam-Hai Chua Director
Carole Piwnica Director and Chair of the Leadership Development and Compensation Committee
HH Sheikh Abdullah bin Khalifa Al Thani Director
Paulo Diniz President
Patrick Pichette board of directors
Joel Cherry President, Research & Development
Jack Newman Chief Science Officer & Co-Founded
Philippe Boisseau Director
John Doerr Director and Chair of the Nominating and Governance Committee
Fernando Reinach Director
R.Neil Williams Director and Chair of the Audit Committee
Past
Jeff Lievense VP Marketing
Andy Meyer Director, Supply & Distribution
Suzy Taherian Finance Operations
Nicholas Khadder Assistant General Counsel

August, 2013

Amyris Signs Agreement for up to $60 Million in Funding from Temasek    amyris.com

February, 2012

Amyris Biotechnologies raised $83.7M in post_ipo_equity round

Amyris Secures $83.7 Million in Additional Financing    businesswire.com

November, 2011

Amyris Biotechnologies acquired Draths Corporation

Amyris Acquires Draths    chemweek.com

October, 2011

Amyris Biotechnologies raised $7M in post_ipo_equity round

SEC    sec.gov

October, 2010

Amyris Biotechnologies raised $13.8M in post_ipo_equity round

SEC    sec.gov

Amyris Biotechnologies IPO
Stock symbol: NASDAQ:AMRS

July, 2010

Amyris Biotechnologies raised $133.2M in a Series D round from Temasek Holdings

SEC    sec.gov

June, 2010

Amyris Enters Into Multi-Products Collaboration and Off-Take Agreements with The Procter and Gamble Company    amyrisbiotech.com

December, 2009

Amyris Biotechnologies raised $24.3M in grant round

SEC Filing Via Liquid Scenarios Search2Model    liquidscenarios.com

October, 2009

Amyris Biotechnologies raised $41.8M in a Series C round from Kleiner Perkins Caufield & Byers, Khosla Ventures, TPG Growth, and Votorantim Novos Negocios

Amyris Closes in on $60M Round for Synthetic Diesel    earth2tech.com

August, 2008

Amyris Biotechnologies raised $21M in a Series B round from DAG Ventures, Khosla Ventures, Kleiner Perkins Caufield & Byers, and TPG Growth

Amyris Picks Up Another $21M For Synthetic Bio    earth2tech.com

February, 2008

Amyris Biotechnologies raised $2.4M in unattributed round

SEC    sec.gov

September, 2007

Amyris Biotechnologies raised $70M in a Series B round from DAG Ventures, Khosla Ventures, Kleiner Perkins Caufield & Byers, and TPG Growth

Amyris Announces $70 Million Series B Round    amyris.com

October, 2006

Amyris Biotechnologies raised $20M in a Series A round from Khosla Ventures, Kleiner Perkins Caufield & Byers, and TPG Growth

Amyris gets $20M from high-profile investors to find alternative fuel    venturebeat.com

2003

Amyris Biotechnologies was founded in 2003